Siemens Healthineers (SHL) Given a €43.00 Price Target at HSBC

HSBC set a €43.00 ($50.00) target price on Siemens Healthineers (ETR:SHL) in a research note released on Monday morning. The firm currently has a buy rating on the stock.

Other research analysts have also issued reports about the stock. UBS Group set a €38.20 ($44.42) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Thursday, August 30th. JPMorgan Chase & Co. set a €38.90 ($45.23) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Thursday, October 25th. Royal Bank of Canada set a €37.00 ($43.02) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Tuesday, October 16th. Morgan Stanley set a €34.00 ($39.53) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Monday, September 17th. Finally, Goldman Sachs Group set a €34.50 ($40.12) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Tuesday, September 25th. Fourteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Siemens Healthineers has an average rating of Hold and a consensus price target of €38.62 ($44.90).

Shares of SHL opened at €38.81 ($45.13) on Monday.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Recommended Story: Why is insider trading harmful?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit